Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

583
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease Modifying Therapy in Multiple Sclerosis.

International scholarly research notices·2016
Same author

Factors associated with prehospital delay among stroke patients in a developing African country.

International journal of stroke : official journal of the International Stroke Society·2015
Same author

Quadriparesis due to simultaneous occurrence of hemorrhagic and ischemic stroke.

International journal of stroke : official journal of the International Stroke Society·2015
Same author

Stray dog trade fuelled by dog meat consumption as a risk factor for rabies infection in Calabar, southern Nigeria.

African health sciences·2014
Same author

Prevalence and pattern of neurocognitive impairment in nigerians with stages 3 to 5 chronic kidney disease.

ISRN neurology·2013
Same author

The burden of inpatient neurologic disease in a tropical African hospital.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2013

Related Experiment Video

Updated: Apr 4, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.2K

Multidisciplinary Interventions in Motor Neuron Disease.

U E Williams1, E E Philip-Ephraim1, S K Oparah1

  • 1Internal Medicine Department, University of Calabar, Calabar, Cross River State 540242, Nigeria.

Journal of Neurodegenerative Diseases
|August 29, 2015
PubMed
Summary

Motor neuron disease (MND) involves progressive loss of motor neurons, leading to rapid decline. Current management includes riluzole, supportive care, and symptom-specific treatments, but more research is needed for comprehensive patient care.

More Related Videos

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.7K
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

17.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.2K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.7K
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

17.5K

Area of Science:

  • Neuroscience
  • Neurology
  • Cellular Biology

Background:

  • Motor neuron disease (MND) is a neurodegenerative condition causing progressive loss of upper and lower motor neurons.
  • Pathogenesis involves mitochondrial dysfunction, oxidative stress, excitotoxicity, and impaired axonal transport.
  • MND leads to significant disability and has a rapid disease progression, with a typical survival of 2-4 years post-onset.

Purpose of the Study:

  • To review current understanding of MND pathogenesis.
  • To summarize evidence-based management strategies for MND.
  • To identify areas requiring further research in MND patient care.

Main Methods:

  • Literature review of proposed pathogenetic processes in MND.
  • Analysis of current evidence for therapeutic interventions.
  • Identification of unmet needs in multidisciplinary MND management.

Main Results:

  • Riluzole is an established disease-modifying drug.
  • Multidisciplinary care, noninvasive ventilation, botulinum toxin B for sialorrhoea, palliative care, and Modafinil for fatigue are supported by evidence.
  • Significant challenges remain in managing dysphagia, secretions, pseudobulbar affect, spasticity, cramps, insomnia, cognitive impairment, and communication.

Conclusions:

  • Current management strategies offer symptomatic relief and disease modification in MND.
  • A multidisciplinary approach is crucial for optimizing patient care.
  • Further research is essential to address the numerous complex symptoms and complications of MND.